LNA Santé Statistics

Total Valuation

LNA Santé has a market cap or net worth of GBP 199.25 million. The enterprise value is 889.48 million.

Market Cap	199.25M
Enterprise Value	889.48M

Important Dates

The next estimated earnings date is Friday, May 2, 2025.

Earnings Date	May 2, 2025
Ex-Dividend Date	Jul 8, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	6.75M

Valuation Ratios

The trailing PE ratio is 11.04.

PE Ratio	11.04
Forward PE	n/a
PS Ratio	0.30
PB Ratio	0.74
P/TBV Ratio	n/a
P/FCF Ratio	2.42
P/OCF Ratio	2.18
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.79, with an EV/FCF ratio of 10.80.

EV / Earnings	49.30
EV / Sales	1.30
EV / EBITDA	6.79
EV / EBIT	16.80
EV / FCF	10.80

Financial Position

The company has a current ratio of 0.91, with a Debt / Equity ratio of 2.71.

Current Ratio	0.91
Quick Ratio	0.37
Debt / Equity	2.71
Debt / EBITDA	5.68
Debt / FCF	8.80
Interest Coverage	2.15

Financial Efficiency

Return on equity (ROE) is 7.25% and return on invested capital (ROIC) is 3.26%.

Return on Equity (ROE)	7.25%
Return on Assets (ROA)	2.56%
Return on Invested Capital (ROIC)	3.26%
Return on Capital Employed (ROCE)	5.54%
Revenue Per Employee	74,115
Profits Per Employee	2,005
Employee Count	9,000
Asset Turnover	0.53
Inventory Turnover	3.27

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.02% in the last 52 weeks. The beta is 0.80, so LNA Santé's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	+19.02%
50-Day Moving Average	25.01
200-Day Moving Average	23.53
Relative Strength Index (RSI)	38.79
Average Volume (20 Days)	122

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LNA Santé had revenue of GBP 667.04 million and earned 18.04 million in profits. Earnings per share was 1.76.

Revenue	667.04M
Gross Profit	224.07M
Operating Income	51.61M
Pretax Income	28.07M
Net Income	18.04M
EBITDA	127.53M
EBIT	51.61M
Earnings Per Share (EPS)	1.76

Full Income Statement

Balance Sheet

The company has 62.07 million in cash and 724.79 million in debt, giving a net cash position of -662.72 million.

Cash & Cash Equivalents	62.07M
Total Debt	724.79M
Net Cash	-662.72M
Net Cash Per Share	n/a
Equity (Book Value)	267.58M
Book Value Per Share	25.38
Working Capital	-31.57M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 91.33 million and capital expenditures -8.95 million, giving a free cash flow of 82.38 million.

Operating Cash Flow	91.33M
Capital Expenditures	-8.95M
Free Cash Flow	82.38M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 33.59%, with operating and profit margins of 7.74% and 2.70%.

Gross Margin	33.59%
Operating Margin	7.74%
Pretax Margin	4.21%
Profit Margin	2.70%
EBITDA Margin	19.12%
EBIT Margin	7.74%
FCF Margin	12.35%

Dividends & Yields

This stock pays an annual dividend of 0.51, which amounts to a dividend yield of 2.21%.

Dividend Per Share	0.51
Dividend Yield	2.21%
Dividend Growth (YoY)	18.40%
Years of Dividend Growth	3
Payout Ratio	28.13%
Buyback Yield	-0.03%
Shareholder Yield	2.18%
Earnings Yield	9.05%
FCF Yield	41.35%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LNA Santé has an Altman Z-Score of 0.76. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.76
Piotroski F-Score	n/a